Loss of S-100-positive Schwann cells is a feature of JAK2 V617F-positive myeloproliferative neoplasm

被引：0
|
作者：
Chhagan Bihari
Archana Rastogi
Priyanka Saxena
Anupam Kumar
机构：
[1] Institute of Liver and Biliary Sciences,Department of Pathology
[2] Institute of Liver and Biliary Sciences,Department of Hematology
[3] Institute of Liver and Biliary Sciences,Department of Research
来源：
Annals of Hematology | 2015年 / 94卷
关键词：
Chronic Myeloid Leukemia; Schwann Cell; Essential Thrombocythemia; Total Leukocyte Count; JAK2 V617F;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1427 / 1429
页数：2
相关论文
共 50 条
  • [1] Loss of S-100-positive Schwann cells is a feature of JAK2 V617F-positive myeloproliferative neoplasm
    Bihari, Chhagan
    Rastogi, Archana
    Saxena, Priyanka
    Kumar, Anupam
    ANNALS OF HEMATOLOGY, 2015, 94 (08) : 1427 - 1429
  • [2] Gender Differences In the Prevalence of Thrombosis In the JAK2 V617F-Positive Myeloproliferative Disorders
    Stein, Brady L.
    Moliterno, Alison R.
    Spivak, Jerry L.
    BLOOD, 2010, 116 (21) : 1270 - 1270
  • [3] A GERMLINE JAK2 SNP IS ASSOCIATED WITH PREDISPOSITION TO THE DEVELOPMENT OF JAK2 V617F-POSITIVE MYELOPROLIFERATIVE NEOPLASMS
    Kilpivaara, M.
    Mukherjee, S.
    Schram, M.
    Wadleigh, M.
    Mullally, A.
    Ebert, L.
    Bass, A.
    Marubayashi, S.
    Heguy, A.
    Garcia-Manero, G.
    Kantarjian, H.
    Offit, K.
    Stone, M.
    Gilliland, D.
    Klein, J.
    Levine, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 420 - 420
  • [4] Disease burden at the progenitor level is a feature of primary myelofibrosis a multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients
    Stein, Brady L.
    Williams, Donna M.
    Rogers, Ophelia
    Isaacs, Mary Ann
    Spivak, Jerry L.
    Moliterno, Alison R.
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (01) : 95 - 101
  • [5] Mesenteric venous thrombosis secondary to an unsuspected JAK2 V617F-positive myeloproliferative disorder
    M. G. Bourke
    S. T. Martin
    M. O’Dwyer
    J. Hanaghan
    F. Bennani
    M. K. Barry
    Irish Journal of Medical Science, 2012, 181 : 285 - 287
  • [6] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Mayumi Tanaka
    Toshiaki Yujiri
    Shunsuke Ito
    Naoko Okayama
    Toru Takahashi
    Kenji Shinohara
    Yoichi Azuno
    Ryouhei Nawata
    Yuji Hinoda
    Yukio Tanizawa
    International Journal of Hematology, 2013, 97 : 409 - 413
  • [7] The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasms
    Shivarov, Velizar
    Tsvetkova, Gergana
    Hadjiev, Evgueniy
    Ivanova, Milena
    HUMAN IMMUNOLOGY, 2023, 84 (03) : 199 - 207
  • [8] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Tanaka, Mayumi
    Yujiri, Toshiaki
    Ito, Shunsuke
    Okayama, Naoko
    Takahashi, Toru
    Shinohara, Kenji
    Azuno, Yoichi
    Nawata, Ryouhei
    Hinoda, Yuji
    Tanizawa, Yukio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 409 - 413
  • [9] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Brazilian patients
    Macedo, L. C.
    Santos, B. C.
    Pagliarini-E-Silva, S.
    Pagnano, K. B. B.
    Rodrigues, C.
    Quintero, F. C.
    Ferreira, M. E.
    Baraldi, E. C.
    Ambrosio-Albuquerque, E. P.
    Sell, A. M.
    Visentainer, J. E. L.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (05) : 654 - 660
  • [10] Mesenteric venous thrombosis secondary to an unsuspected JAK2 V617F-positive myeloproliferative disorder
    Bourke, M. G.
    Martin, S. T.
    O'Dwyer, M.
    Hanaghan, J.
    Bennani, F.
    Barry, M. K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 (02) : 285 - 287
12345